BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• 

  Drug Development

  Despite Late-Stage Hemophilia Win, Sangamo Remains in Do-or-Die Situation

  Sangamo and Pfizer’s hemophilia A gene therapy candidate scored a Phase III victory last week. However, with the genomic medicine company soon to run out of cash, Sangamo’s short-term prospects look bleak but not unsalvageable, analysts say.
  

  July 31, 2024

   · 

  3 min read

   · 

  Tyler Patchen
• Press Releases

  Theriva™ Biologics Receives Rare Pediatric Drug Designation by the U.S. FDA for VCN-01 for the Treatment of Retinoblastoma

  July 31, 2024

   · 

  6 min read
• Press Releases

  Athira Pharma Presents Preclinical Data Demonstrating New Insights into the Mechanism by Which Fosgonimeton Protects Neurons from Alzheimer’s Disease-Related Pathology at the Alzheimer’s Association International Conference (AAIC) 2024

  July 31, 2024

   · 

  7 min read
• Press Releases

  Ardelyx Announces Publication of Two Plain Language Summaries from XPHOZAH® (tenapanor) Clinical Trials in Current Medical Research and Opinion

  July 31, 2024

   · 

  6 min read
• Press Releases

  Achieve Life Sciences Announces FDA Grants Breakthrough Therapy Designation to Cytisinicline for the Treatment of E-Cigarette or Vaping Nicotine Dependence

  July 31, 2024

   · 

  7 min read
• Press Releases

  Immutep Quarterly Activities Report Q4 FY24

  July 31, 2024

   · 

  13 min read
• Press Releases

  Tonix Pharmaceuticals Announces Potential Positive Impact of the U.S. National Academies (NASEM) New Definition of Long COVID on the Size of the Fibromyalgia Market for Tonmya™

  July 31, 2024

   · 

  11 min read
• Press Releases

  IMUNON Announces $10 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

  July 31, 2024

   · 

  5 min read
• Press Releases

  Rezolute to Participate in the BTIG Virtual Biotechnology Conference

  July 31, 2024

   · 

  1 min read
• Press Releases

  electroCore to Announce Second Quarter June 30, 2024 Financial Results on Wednesday, August 7, 2024

  July 31, 2024

   · 

  1 min read